Radiopharm Theranostics Presents Phase 2b Imaging Study Data for RAD101
Radiopharm Theranostics presented interim analysis from its Phase 2b imaging study of RAD101 in suspected recurrent brain metastases at the 31st Society for Neuro-Oncology Annual Meeting.